AU531965B2 - Babesiosis antigen - Google Patents

Babesiosis antigen

Info

Publication number
AU531965B2
AU531965B2 AU57764/80A AU5776480A AU531965B2 AU 531965 B2 AU531965 B2 AU 531965B2 AU 57764/80 A AU57764/80 A AU 57764/80A AU 5776480 A AU5776480 A AU 5776480A AU 531965 B2 AU531965 B2 AU 531965B2
Authority
AU
Australia
Prior art keywords
babesiosis
antigen
babesiosis antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57764/80A
Other languages
English (en)
Other versions
AU5776480A (en
Inventor
Carlos Arellano
Miodrag Ristic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois Foundation
Original Assignee
University of Illinois at Urbana Champaign
University of Illinois Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois at Urbana Champaign, University of Illinois Foundation filed Critical University of Illinois at Urbana Champaign
Publication of AU5776480A publication Critical patent/AU5776480A/en
Application granted granted Critical
Publication of AU531965B2 publication Critical patent/AU531965B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A61K39/018—Babesia antigens, e.g. Theileria antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU57764/80A 1979-04-30 1980-04-24 Babesiosis antigen Ceased AU531965B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3466479A 1979-04-30 1979-04-30
US034664 1979-04-30
US06/130,481 US4596707A (en) 1979-04-30 1980-03-31 Babesia parasite antigen useful in vaccine and diagnostic reagent
US130481 1980-03-31

Publications (2)

Publication Number Publication Date
AU5776480A AU5776480A (en) 1980-11-06
AU531965B2 true AU531965B2 (en) 1983-09-15

Family

ID=26711229

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57764/80A Ceased AU531965B2 (en) 1979-04-30 1980-04-24 Babesiosis antigen

Country Status (8)

Country Link
US (1) US4596707A (OSRAM)
EP (1) EP0018579B1 (OSRAM)
AU (1) AU531965B2 (OSRAM)
DE (1) DE3064090D1 (OSRAM)
GR (1) GR68201B (OSRAM)
IE (1) IE49590B1 (OSRAM)
IL (1) IL59841A (OSRAM)
PT (1) PT71169A (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0124548A4 (en) * 1982-11-10 1985-04-25 Commw Scient Ind Res Org BABESIOSIS ANTIGEN AND PREPARATION METHOD.
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
FR2589063B1 (fr) * 1985-10-24 1988-08-26 Rhone Merieux Procede de culture de babesia canis, application a la preparation d'antigenes et de vaccins, et antigenes et vaccins contre la piroplasmose
US4721617A (en) * 1986-08-14 1988-01-26 Regents Of The University Of Minnesota Vaccine against lyme disease
GB8630851D0 (en) * 1986-12-24 1987-02-04 Department Of Agriculture For Babesia divergens antigen & vaccine
US5273884A (en) * 1989-01-25 1993-12-28 Commonwealth Scientific & Industrial Polypetides, antigens or vaccines protective against babesiosis
FR2655853B1 (fr) * 1989-12-20 1994-06-10 Centre Nat Rech Scient Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes.
US5643737A (en) * 1992-06-22 1997-07-01 The United States Of America As Represented By The Secretary Of Agriculture Merozoite proteins for use in detection of Babesia equi in horses using immunological techniques
EP0691131B1 (en) * 1994-06-06 1999-10-06 Akzo Nobel N.V. Babesia vaccine
ES2141297T3 (es) * 1994-06-06 2000-03-16 Akzo Nobel Nv Vacuna contra la babesiosis.
FR2724392B1 (fr) * 1994-09-08 1996-12-13 Virbac Lab Procedes de culture, d'attenuation de la virulence et de clonage in vitro de parasites du genre babesia et leurs applications
US6214971B1 (en) * 1996-10-01 2001-04-10 Corixa Corporation Compounds and methods for the diagnosis and treatment of Babesia microti infection
US6451315B1 (en) 1996-10-01 2002-09-17 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6569433B1 (en) 1996-10-01 2003-05-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
US6306396B1 (en) 1996-10-01 2001-10-23 Corixa Corporation Compounds and methods for the diagnosis and treatment of B. microti infection
RU2373954C1 (ru) * 2008-04-28 2009-11-27 Общество с ограниченной ответственностью "ШИ-КОН" Способ приготовления вакцины против кровепаразитарных инфекций
RU2429010C2 (ru) * 2009-10-14 2011-09-20 Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко (ВИЭВ) Способ получения высокоактивных и высокоспецифичных антигенов для диагностики бабезиоза собак в серологических реакциях
CN106978425B (zh) * 2017-02-17 2019-10-18 华中农业大学 东方巴贝斯虫1-脱氧-d-木酮糖-5-磷酸还原异构酶基因及其编码的蛋白
EP4061410A4 (en) * 2019-11-21 2024-05-22 Griffith University IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE EXTRACTS AND CORRESPONDING USES

Also Published As

Publication number Publication date
IL59841A (en) 1983-10-31
PT71169A (en) 1980-05-01
IE49590B1 (en) 1985-10-30
GR68201B (OSRAM) 1981-11-10
EP0018579A3 (en) 1981-03-25
IL59841A0 (en) 1980-06-30
DE3064090D1 (en) 1983-08-18
AU5776480A (en) 1980-11-06
EP0018579B1 (en) 1983-07-13
IE800858L (en) 1980-10-30
EP0018579A2 (en) 1980-11-12
US4596707A (en) 1986-06-24

Similar Documents

Publication Publication Date Title
AU544254B2 (en) Methods
AU538496B2 (en) Methods
AU523622B2 (en) Solar-cell-grade silicon
AU532879B2 (en) 1-aryl-2-acylamido-3-fluoro-1-propanols
AU532626B2 (en) Monacolink
AU532090B2 (en) Emmitter
AU532783B2 (en) 4-aroyl-imazol-2-ones
AU535632B2 (en) Cyclo-octapeptides
AU531965B2 (en) Babesiosis antigen
AU529508B2 (en) 6-n-propyl-8alpha-methoxymethyl or -methylmercaptomethyl -ergolines
AU533526B2 (en) Polyether-polyamines
AU525431B2 (en) Emulsans
AU532884B2 (en) Vinyl-cephalosporins
AU528665B2 (en) Breathalyser
AU527992B2 (en) 9-aminoalkylfluorenes
AU532763B2 (en) 8-aminoalkyl-4-alkylpsoralens
AU533807B2 (en) Pyridothienotriazines
AU531808B2 (en) Tetrahydrobenzothiazolylimidazolidinones
AU531811B2 (en) Thiazolylidene-oxo-propionitriles
AU532359B2 (en) 2-amino-3-benzoyl-phenylacetamides
AU532700B2 (en) Diphenylalkanoether
AU528075B2 (en) Z-aza-ergolines
AU535376B2 (en) N-oximinoalkyl-anilides
AU531825B2 (en) 4-beta-substituted-2-azetidinones
AU534662B2 (en) Azolyl-alkenols